Hama HealthTech provides independent consulting services focused on market access and reimbursement strategy for MedTech, diagnostics, and digital health technologies.
Our work supports companies in understanding reimbursement environments, payer requirements, and evidence expectations across international healthcare systems.
Services
Global Market Access Landscape Analysis
Comprehensive assessment of reimbursement and payer environments across major healthcare markets.
This includes analysis of reimbursement pathways, HTA processes, payer structures, and market access considerations.
Reimbursement Pathway Analysis
Evaluation of potential coding, coverage, and payment pathways within healthcare systems.
The analysis identifies possible routes for reimbursement and highlights key considerations for successful payer adoption.
HTA Intelligence & Evidence Landscape
Monitoring and analysis of HTA evaluations, clinical evidence expectations, and technology assessments conducted by international HTA organizations such as National Institute for Health and Care Excellence.
Market Access Feasibility Assessment
Early-stage evaluation of reimbursement feasibility for emerging health technologies.
This service helps companies identify potential barriers, payer requirements, and strategic considerations before market entry.
Digital Health MVP Development
Support for digital health innovators through rapid development of MVP applications and prototypes using no-code platforms.
These prototypes can support early product validation, pilot testing, and clinical or market feasibility studies.